A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF)

NCT03150719 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Tezacaftor/Ivacaftor
DRUG: Ivacaftor
DRUG: Placebo
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated